Galena Biopharma to Present at the 2016 Aegis Growth Conference
Sep 14, 2016 11:05 am UTC| Business
SAN RAMON, Calif., Sept. 14, 2016 -- Galena Biopharma, Inc. (NASDAQ:GALE), a biopharmaceutical company committed to the development and commercialization of hematology and oncology therapeutics that address unmet...
Xura Appoints Ronald J. de Lange to its Board of Directors
Sep 14, 2016 11:01 am UTC| Business
WAKEFIELD, Mass., Sept. 14, 2016 -- Xura, Inc., a leading provider of digital communications services, today announced the appointment of Ronald J. de Lange to its Board of Directors, effective immediately. With a...
Amdocs Acquires Three Leading Technology Companies to Expand Digital Offering
Sep 14, 2016 11:00 am UTC| Business
ST. LOUIS, Sept. 14, 2016 -- Amdocs (NASDAQ:DOX), the leading provider of customer experience solutions, today announced it has closed the acquisition of three privately owned companies – Vindicia, Brite:Bill and Pontis...
Pluristem Advances Towards U.S. Clinical Trial in PLX-R18 and Announces Principal Investigator
Sep 14, 2016 11:00 am UTC| Business
Dr. Hillard Lazarus of Case Western Reserve University will be the Principal Investigator of the trialThe trial protocol was cleared by the U.S. FDAIncomplete engraftment after HCT is one of several hematologic indications...
New Report Ranks 15 Top Banks on Mobile Deposit Customer Experience
Sep 14, 2016 11:00 am UTC| Business
SAN DIEGO and LONDON, Sept. 14, 2016 -- Mitek (NASDAQ:MITK), (www.miteksystems.com), a global leader in mobile capture and identity verification software solutions, today announced the release of new research from the...
Plug Power and Mitsubishi Nichiyu Show Fuel Cell Powered Forklift at Logis Tech Tokyo
Sep 14, 2016 11:00 am UTC| Business
LATHAM, N.Y., Sept. 14, 2016 -- Plug Power Inc. (NASDAQ:PLUG), a leader in providing energy solutions that change the way the world moves, announces that Mitsubishi Nichiyu Forklift is displaying one of the company’s...
Anavex to Participate in Mizuho Therapeutics Conference
Sep 14, 2016 11:00 am UTC| Business
NEW YORK, Sept. 14, 2016 -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq:AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative...